Cooper Companies (The) vs Zoetis

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (75 vs 79)
Cooper Companies (The) logo

Cooper Companies (The)

LeaderHealthcare Tech

Enterprise

San Ramon CA contact lenses and fertility devices (NASDAQ: COO) $3.87B FY2024 revenue (+9%); CooperVision MiSight myopia management, CooperSurgical IVF consumables, competing with J&J Vision and Alcon.

AI VisibilityBeta
Overall Score
B75
Category Rank
#77 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
78
Gemini
74

About

The Cooper Companies, Inc. is a San Ramon, California-based medical device company — publicly traded on the NASDAQ (NASDAQ: COO) as an S&P 500 Health Care component — operating two segments: CooperVision (soft contact lenses for vision correction globally — the second-largest contact lens manufacturer worldwide) and CooperSurgical (fertility and women's health medical devices including IVF laboratory consumables, assisted reproductive technology products, and gynecological surgical instruments) through approximately 15,000 employees in 130 countries. In fiscal year 2024 (ending October 2024), Cooper Companies reported revenues of $3.87 billion (+9% organic growth), with CooperVision generating $2.56 billion from daily, biweekly, and monthly contact lens sales across sphere, toric (astigmatism-correcting), and multifocal (presbyopia-correcting) lens categories, and CooperSurgical generating $1.31 billion from fertility clinic consumables and women's health surgical products. CEO Albert White has executed CooperVision's strategy of capturing the premium daily silicone hydrogel lens market: silicone hydrogel material (higher oxygen permeability improving eye health versus conventional hydrogel) commands a 20-30% price premium over conventional daily lenses, and Cooper's MyDay (premium daily silicone hydrogel) and clariti (value silicone hydrogel) brands compete across price tiers against Johnson & Johnson Vision's Acuvue Oasys and CIBA Vision's AIR OPTIX brands for the global market shift toward dailies — the fastest-growing contact lens modality as patients prefer the convenience and hygiene of discarding lenses after each day's wear.

Full profile
Zoetis logo

Zoetis

LeaderHealthcare Tech

Animal Health

Zoetis (ZTS) reported ~$9.1B revenue in FY2024. World's largest animal health company developing medicines, vaccines, and diagnostics for companion animals and livestock. HQ: Parsippany, NJ.

AI VisibilityBeta
Overall Score
B79
Category Rank
#32 of 596
AI Consensus
66%
Trend
stable
Per Platform
ChatGPT
81
Perplexity
73
Gemini
84

About

Zoetis Inc. is the world's largest animal health company, developing, manufacturing, and commercializing medicines, vaccines, diagnostics, and other technologies for companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish). Spun off from Pfizer in 2013, Zoetis has maintained its position as the global leader in animal health with approximately 300 product lines serving veterinarians, livestock producers, and pet owners in over 100 countries.

Full profile

AI Visibility Head-to-Head

75
Overall Score
79
#77
Category Rank
#32
80
AI Consensus
66
stable
Trend
stable
79
ChatGPT
81
78
Perplexity
73
74
Gemini
84
77
Claude
73
71
Grok
84

Key Details

Category
Enterprise
Animal Health
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Zoetis
Animal Health

Integrations

Only Cooper Companies (The)
Cooper Companies (The) is classified as company. Zoetis is classified as company (part of Pfizer).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.